Khuri ET - Search Results

1

Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: therapeutic, historical, and ethical aspects.

Novick DM, Kreek MJ, Des Jarlais DC, Spira TJ, Khuri ET, Ragunath J, Kalyanaraman VS, Gelb AM, Miescher A. Novick DM, et al. Among authors: khuri et. NIDA Res Monogr. 1986;67:318-20. NIDA Res Monogr. 1986. PMID: 3092085 No abstract available.

2

Long-term followup studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: liver disease and immune status.

Kreek MJ, Khuri E, Fahey L, Miescher A, Arns P, Spagnoli D, Craig J, Millman R, Harte EH. Kreek MJ, et al. NIDA Res Monogr. 1986;67:307-9. NIDA Res Monogr. 1986. PMID: 3092083 No abstract available.

3

Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patients.

Kennedy JA, Hartman N, Sbriglio R, Khuri E, Albeck H, Kreek MJ. Kennedy JA, et al. NIDA Res Monogr. 1990;105:416. NIDA Res Monogr. 1990. PMID: 1876057 No abstract available.

4

Immune status of unselected methadone maintained former heroin addicts.

Kreek MJ, Khuri E, Flomenberg N, Albeck H, Ochshorn M. Kreek MJ, et al. Prog Clin Biol Res. 1990;328:445-8. Prog Clin Biol Res. 1990. PMID: 2304962 No abstract available.

5

Psychiatric comorbidity in methadone maintained patients.

Mason BJ, Kocsis JH, Melia D, Khuri ET, Sweeney J, Wells A, Borg L, Millman RB, Kreek MJ. Mason BJ, et al. Among authors: khuri et. J Addict Dis. 1998;17(3):75-89. doi: 10.1300/J069v17n03_07. J Addict Dis. 1998. PMID: 9789161

6

Alcohol use in youthful methadone-maintained former heroin addicts: liver impairment and treatment outcome.

Hartman N, Kreek MJ, Ross A, Khuri E, Millman RB, Rodriguez R. Hartman N, et al. Alcohol Clin Exp Res. 1983 Summer;7(3):316-20. doi: 10.1111/j.1530-0277.1983.tb05469.x. Alcohol Clin Exp Res. 1983. PMID: 6353983 No abstract available.

7

Clinical issues concerning alcoholic youthful narcotic abusers.

Khuri ET, Millman RB, Hartman N, Kreek MJ. Khuri ET, et al. Adv Alcohol Subst Abuse. 1984 Summer;3(4):69-86. doi: 10.1300/J251v03n04_07. Adv Alcohol Subst Abuse. 1984. PMID: 6507186

8

Metyrapone-induced withdrawal symptoms.

Kennedy JA, Hartman N, Sbriglio R, Khuri E, Kreek MJ. Kennedy JA, et al. Br J Addict. 1990 Sep;85(9):1133-40. doi: 10.1111/j.1360-0443.1990.tb03438.x. Br J Addict. 1990. PMID: 2224193

9

Effects of the opioid antagonist naloxone on human natural killer cell activity in vitro.

Adelson MO, Novick DM, Khuri E, Albeck H, Hahn EF, Kreek MJ. Adelson MO, et al. Isr J Med Sci. 1994 Sep;30(9):679-84. Isr J Med Sci. 1994. PMID: 8088979

10

Working with heroin sniffers: clinical issues in preventing drug injection.

Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Casriel C, et al. J Subst Abuse Treat. 1990;7(1):1-10. doi: 10.1016/0740-5472(90)90031-k. J Subst Abuse Treat. 1990. PMID: 2313766

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page